Results 151 to 160 of about 110,265 (199)

Destination therapy: time for real progress

Nature Clinical Practice Cardiovascular Medicine, 2008
Both prognosis and quality of life are poor for severely symptomatic patients with stage D heart failure, and treatment options are limited. Few individuals are eligible for cardiac transplantation, and ventricular resynchronization therapy provides only marginal benefit in select patients.
openaire   +2 more sources

Ventricular assist devices as destination therapy

Surgical Clinics of North America, 2004
The prospects for long-term mechanical circulatory support are improving. Axial flow pumps are a promising competitor to pulsatile first-generation LVADs, although the two may serve different patient populations. Centrifugal pumps are in the development phase and seem to require less anticoagulation.
openaire   +2 more sources

Older Destination Therapy Patient Selection

2013
Portions of this chapter were presented at the 29th Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation, April 2009, Paris, France and the 31st Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation, April 2011, San Diego, California, USA.
Robert M. Adamson, Walter P. Dembitksy
openaire   +1 more source

Destination Health: Doc Feelgood’s Rock Therapy

Popular Music and Society, 2021
Medical imagery has been a staple within recorded song lyrics since 1890. Its manifestations vary greatly, of course.
openaire   +1 more source

Herztransplantation und „Destination“-Therapie – Update 2018

DMW - Deutsche Medizinische Wochenschrift, 2018
Was ist neu? Zurückhaltung bei der Organspende Der auch im vergangenen Jahr deutliche Rückgang der Bereitschaft zur Organspende hat Auswirkungen auf die Therapie der terminalen Herzinsuffizienz. Wenn auch die Herztransplantation weiterhin den Goldstandard darstellt, kann infolge des Organmangels nur ein geringer und zumeist schwersterkrankter
Diyar Saeed, Ralf Westenfeld
openaire   +2 more sources

Destination Therapy: Patient Selection and Current Outcomes

Journal of Cardiac Surgery, 2010
Long-term left-ventricular assist device (LVAD) support as destination therapy (DT) is a promising new alternative for the growing population of patients with advanced heart failure. In this article, we summarize the clinical trials that led to the approval of LVAD use as DT in the US national policies regulating candidate selection and DT center ...
openaire   +2 more sources

Ventricular Assist Devices for Destination Therapy

2013
Heart failure is a growing public health problem in United States with prevalence of 10 % in population aged 65 and above. Although cardiac transplant is “gold standard” therapy for end-stage heart failure, its use is restricted largely to younger patients (
Sanjeev Aggarwal, Mark S. Slaughter
openaire   +1 more source

Outcomes Using LVADs for Destination Therapy

2017
The goal of this chapter is to present the data from pivotal trials that have studied the outcomes of patients with end-stage heart failure who were deemed ineligible for heart transplantation in whom left ventricular assist devices were used as destination therapy. Data suggest left ventricular assist devices are superior to optimal medical therapy in
Priyanka Sen, Selby Oberton
openaire   +1 more source

An Implantable Aortic Valvo-pump for Destination Therapy

Cardiovascular Engineering, 2006
To investigate the possibility of a long-term applicable left ventricular assist device, a 23 mm outer diameter and 31 g weight implantable aortic valvo-pump was developed. It consists of a rotor and a stator; the rotor has a driven magnets assemble and an impeller, the stator has a motor coil with iron core and a outflow guide vane. The device locates
openaire   +2 more sources

Utilisation du Jarvik 2000 en Destination Therapy

2018
JCTCV:22(2)
Barthélemy, Béatrice, Lebreton, Guillaume, Niculescu, Michaela, Leprince, Pascal   +3 more
openaire   +1 more source